This module allows you to analyze existing cross correlation between Alnylam Pharmaceuticals and NIKKEI 225. You can compare the effects of market volatilities on Alnylam Pharmaceuticals and NIKKEI 225 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alnylam Pharmaceuticals with a short position of NIKKEI 225. See also your portfolio center. Please also check ongoing floating volatility patterns of Alnylam Pharmaceuticals and NIKKEI 225.
|Horizon||30 Days Login to change|
Predicted Return Density
Alnylam Pharmaceuticals Inc vs. NIKKEI 225
Given the investment horizon of 30 days, Alnylam Pharmaceuticals is expected to generate 3.21 times more return on investment than NIKKEI 225. However, Alnylam Pharmaceuticals is 3.21 times more volatile than NIKKEI 225. It trades about 0.06 of its potential returns per unit of risk. NIKKEI 225 is currently generating about 0.12 per unit of risk. If you would invest 7,589 in Alnylam Pharmaceuticals on September 16, 2019 and sell it today you would earn a total of 575.00 from holding Alnylam Pharmaceuticals or generate 7.58% return on investment over 30 days.
Pair Corralation between Alnylam Pharmaceuticals and NIKKEI 225
|Time Period||3 Months [change]|
Diversification Opportunities for Alnylam Pharmaceuticals and NIKKEI 225
Overlapping area represents the amount of risk that can be diversified away by holding Alnylam Pharmaceuticals Inc and NIKKEI 225 in the same portfolio assuming nothing else is changed. The correlation between historical prices or returns on NIKKEI 225 and Alnylam Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alnylam Pharmaceuticals are associated (or correlated) with NIKKEI 225. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NIKKEI 225 has no effect on the direction of Alnylam Pharmaceuticals i.e. Alnylam Pharmaceuticals and NIKKEI 225 go up and down completely randomly.
See also your portfolio center. Please also try Fundamental Analysis module to view fundamental data based on most recent published financial statements.